Will your plan pay for this use?
The medicine has approval, but your insurance answer is still unclear. What is the missing piece?
Give the plan the exact product, its form, and the reason for treatment. Ask for an answer tied to your policy.
Ask about the plan’s list and permission step
Look for the formulary: it lists the medicines your plan pays for. If prior authorization is required, the plan has to say yes to payment before you fill the prescription.
- Is this product on my plan’s list for this reason for treatment?
- Does it need prior authorization?
- Who sends the required records?
- How much do I owe for visits, and how much for medicine?
The Food and Drug Administration (FDA) could approve a use without an insurer agreeing to pay for it, as checked September 26, 2026.
Medicare has different routes
Part D is Medicare coverage that helps with the cost of prescribed medicines.
As checked on September 26, 2026, Part D could pay for Mounjaro (tirzepatide) for type 2 diabetes. It could also pay for Zepbound (tirzepatide) for sleep apnea, when breathing is repeatedly blocked during sleep, if the condition met the coverage rules.
The plan’s own list and prior authorization still applied.
People who qualified for the Medicare GLP-1 Bridge could get weight care with a $50 monthly copay, as checked September 26, 2026. This was a temporary program.
The program’s name refers to a signal made in the gut that helps control appetite and blood sugar. Tirzepatide acts on that signal.
For a bill with a copay, that amount is what the patient pays.
The Bridge’s start date was July 1, 2026; its last day was December 31, 2027, under the terms recorded on September 26, 2026.
For tirzepatide, the program included only Zepbound’s KwikPen as of September 26, 2026. It did not include vials, which are small medicine bottles, or pens that hold just one dose.
KwikPen is a pen with several doses inside.
The age rule for the Bridge, checked September 26, 2026, set 18 as the minimum. An older adult meets that minimum age. Your weight, health conditions, and Medicare plan also had to meet the program’s rules. A prescription and agreement to pay in advance were required.
People with type 2 diabetes had to seek payment through ordinary Part D instead of the Bridge, under the September 26, 2026 rules.
Under the September 26, 2026 terms, the Bridge payment was separate from your usual Part D drug costs. Part D has a yearly limit on what you pay for covered medicines. Paying the Bridge’s $50 did not move you closer to that limit. The Bridge also gave no extra help with its fee to people with low incomes.
Ask your plan and prescriber to check your route. The headline fee does not establish that you qualify.
Savings cards have their own limits
For the maker’s tirzepatide savings cards, the September 26, 2026 terms limited use to people with commercial insurance. Medicare, Medicaid, and military health plans were excluded.
A plan from work or a private insurer is called commercial insurance.
The cards had savings caps and a December 31, 2026 end date.
If you cannot use a savings card, ask whether a cash-price offer is available for your prescription. Being turned down for the card does not automatically stop you from using a cash offer.
Check the government’s coverage notes
Medicare’s weight-drug coverage page
This page explains the temporary Bridge. Use it to ask your plan whether you qualify.
The Bridge’s product and eligibility details
This more detailed page sets out which products and forms qualify, plus the rules a prescriber needs to check.